Immunovant Inc (IMVT) USD0.0001
1.81%- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$26.97
Buy:$26.98
Change:
$0.12
(0.45%)
$0.12
(0.45%)Market closed |
Prices delayed by at least 15 minutes
Sell:$26.97
Buy:$26.98
Change:$0.12
(0.45%)
$0.12
(0.45%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 December 2025 | ROIVANT SCIENCES LTDParent Company | Buy Regular purchase transaction | 16,666,666 | $21.00 | $349,999,986.00 | 113,317,007 |
| 1 December 2025 | Douglas J. (Dough) HughesIndependent Director | Sell Regular sell transaction (market) | 13,091 | $23.14 | $302,925.74 | 122,682 |
| 1 December 2025 | Douglas J. (Dough) HughesIndependent Director | Sell Regular sell transaction (market) | 1,909 | $23.96 | $45,739.64 | 120,773 |
| 1 December 2025 | Andrew J (Drew) FromkinDirector | Sell Regular sell transaction (market) | 19,351 | $23.14 | $447,782.14 | 88,750 |
| 1 December 2025 | Andrew J (Drew) FromkinDirector | Sell Regular sell transaction (market) | 2,898 | $23.95 | $69,407.10 | 85,852 |
| 20 November 2025 | Melanie GloriaCOO | Sell Tax related | 10,251 | $23.54 | $241,308.54 | 175,886 |
| 20 November 2025 | Melanie GloriaCOO | Sell Tax related | 2,375 | $23.97 | $56,928.75 | 173,511 |
| 22 October 2025 | Michael GeffnerChief Level Officer | Sell Tax related | 2,595 | $19.03 | $49,382.85 | 217,958 |
| 22 October 2025 | Jay S StoutCTO | Sell Tax related | 2,520 | $19.03 | $47,955.60 | 200,814 |
| 8 October 2025 | Michael GeffnerChief Level Officer | Sell Tax related | 1,272 | $16.30 | $20,733.60 | 220,553 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 December 2025 | ROIVANT SCIENCES LTDParent Company | Buy Regular purchase transaction | 16,666,666 | $21.00 | $349,999,986.00 | 113,317,007 |
| 13 January 2025 | ROIVANT SCIENCES LTDParent Company | Buy Regular purchase transaction | 16,845,010 | $20.00 | $336,900,200.00 | 96,650,341 |
| 1 December 2025 | Andrew J (Drew) FromkinDirector | Sell Regular sell transaction (market) | 19,351 | $23.14 | $447,782.14 | 88,750 |
| 9 April 2025 | Peter (Pete) SalzmannCEO | Sell Tax related | 28,094 | $12.99 | $364,941.06 | 1,186,512 |
| 19 February 2025 | Peter (Pete) SalzmannCEO | Sell Tax related | 15,439 | $20.86 | $322,057.54 | 948,786 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.